Related Experiment Video
Updated: Feb 5, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Selected summary for the 2015 Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE)
1Liver Cancer Program, Divisions of Liver Diseases & Hematology/Medical Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, NY 10029, USA.
Abstract:
Liver cancer is now ranked second in terms of cancer-related mortality worldwide; with limited treatment options for patients at advanced stages it remains a growing health problem. All Phase III clinical trials testing molecular therapies after sorafenib have so far failed, and there is still not a validated oncogene addiction loop. Despite the present huge challenges, advancements in the recent years have been remarkable. The Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE) was designed to promote scientific exchanges of international and regional experts in the study and management of liver cancer. Over the years it has consolidated as a major resource to provide a thorough update to clinicians and researchers located in the Asia-Pacific region in different aspects of liver cancer. Attendance at these meetings is exceptional, with an average of 1000 attendees at each conference. As predicted, the 2015 edition provided an outstanding overview of the latest developments in the clinical management and molecular pathogenesis of the disease.
Insights
Liver cancer is a leading cause of cancer death globally. The 2015 Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE) highlighted recent advancements in managing this complex disease.
Area of Science:
- Hepatology
- Oncology
- Molecular Biology
Background:
- Liver cancer is the second leading cause of cancer mortality worldwide.
- Advanced-stage liver cancer has limited treatment options, posing a significant health challenge.
- Previous molecular therapies post-sorafenib have failed in Phase III trials, and a validated oncogene addiction loop is yet to be identified.
Purpose of the Study:
- To provide a comprehensive update on liver cancer management and molecular pathogenesis.
- To foster scientific exchange among international and regional experts in liver cancer.
- To consolidate the Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE) as a key resource for clinicians and researchers.
Main Methods:
- The content reflects discussions and presentations from the 2015 APPLE conference.
- Expert insights and the latest research findings were shared.
- Focus on clinical management and molecular pathogenesis of liver cancer.
Main Results:
- The 2015 APPLE meeting offered an outstanding overview of recent developments.
- Significant advancements in the clinical management of liver cancer were presented.
- New insights into the molecular pathogenesis of liver cancer were discussed.
Conclusions:
- Despite challenges, remarkable advancements in liver cancer research and treatment are emerging.
- The APPLE meeting serves as a crucial platform for disseminating cutting-edge information in the Asia-Pacific region.
- Continued expert collaboration is vital for addressing the growing burden of liver cancer.
Related Concept Videos
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Discharge Summary Forms
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
What is Natural Selection?
Antibiotic Selection
Types of Selection
Frequency-dependent Selection

